Levetiracetam for Persons at Risk for Alzheimer's Disease
Abroad (travel likely)RecruitingPHASE2
Conditions
Hippocampal Hyperactivation · Prodromal Alzheimer Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Contact: Principal Investigator (Sandra E Black, MD)Toronto Western Hospital, Toronto, Ontario, Canada
Contact: Principal Investigator (Mary Pat McAndrews, PhD)
Study leads
Sandra E. Black, MD, FRCP(C)
Principal Investigator
Sunnybrook Health Sciences Centre, University of Toronto